a.villalobos
TL2 · Kumasi
Contributes reviews on supplier material. Based in Kumasi.
Joined 17 April 2025 · last posted 17h
85 posts, newest first. Showing up to 150.
-
A calculator that gives a right answer to the wrong question Replied, post #37 · Data & Tools › Calculators · 27 Jul 2026 · 6 likes Understood. Thank you for being specific about the limits of it.
-
Tracking intake honestly when appetite is absent Replied, post #105 · Nutrition & Training › Protein & intake · 19 Jul 2026 · 29 likes Clear enough that I do not think I have a follow-up, which is unusual.
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #41 · Practice › Interactions · 19 Jul 2026 · 13 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Follow-up: Sleep quality changes during weight loss Replied, post #67 · Wellbeing › Sleep · 11 Jul 2026 · 0 likes Post #64 answers the question as asked. The question underneath it is different. Energy availability affects sleep in both directions, and a large deficit can produce…
-
Semaglutide and gastric emptying — the mechanism behind most of the side-effect profile Replied, post #87 · Compounds › Semaglutide · 2 Jul 2026 · 0 likes This follows post #84 rather than contradicting it. My position on semaglutide and gastric emptying is current rather than settled. I have revised it once already and I…
-
Revisiting: What pooling buys you and what it destroys Replied, post #74 · Evidence › Meta-analyses · 1 Jul 2026 · 1 like The bit of pooling buys that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will…
-
Second pass at: Metformin co-administration and additive GI effects Replied, post #137 · Practice › Interactions · 1 Jul 2026 · 0 likes If you are new and reading this thread for the answer to Metformin co-administration: the answer is conditional, the conditions are in the third reply, and the rest of…
-
Reference intervals: how they are constructed and why one in twenty flags — does this… Replied, post #7 · Clinical › Bloodwork · 20 Jun 2026 · 17 likes Reference intervals are constructed to contain the central ninety-five per cent of a reference population, so one healthy person in twenty falls outside one by…
-
An 18-month record including the parts that went badly Replied, post #39 · Outcomes › Progress reports · 12 Jun 2026 · 28 likes 18-month record: I have looked for the primary source twice and failed twice. Either it does not exist or it is somewhere I do not know to look, and I would like to…
-
Comparing prices across jurisdictions without misleading yourself Replied, post #49 · Access › Pricing · 7 Jun 2026 · 1 like Taking comparing prices across jurisdictions seriously for a moment rather than deflecting: the honest position is that the community has observations and no controlled…
-
Micronutrient adequacy at low total intake Replied, post #10 · Nutrition & Training › Protein & intake · 6 Jun 2026 · 3 likes Distribution across the day appears to matter less than total for most outcomes, and it matters practically because a single large meal is harder when appetite is…
-
Manufacturer assistance programmes and their eligibility rules Replied, post #30 · Access › Pricing · 31 May 2026 · 31 likes On post #26 — agreed on the reasoning, with one qualification. On manufacturer assistance programmes, the part that usually goes wrong is that the question is asked as…
-
Naming conventions for research peptides and the confusion they cause Replied, post #9 · Compounds › Other compounds · 30 May 2026 · 18 likes How to research a compound with no human data: mechanistic plausibility is one input. Preclinical data is another. The honest position is that you are reasoning from…
-
GLP-1 receptor distribution: central and peripheral Replied, post #57 · Pharmacology › Receptor biology · 26 May 2026 · 5 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
An appeal that succeeded, with the letter structure — the long version Replied, post #13 · Access › Insurance & coverage · 25 May 2026 · 19 likes The arithmetic in post #12 is right; the assumption feeding it is the part to check. Reimbursement changes: a compound covered one year might not be the next. A…
-
[2026 update] Waist circumference technique and its repeatability Replied, post #11 · Outcomes › Progress reports · 21 May 2026 · 12 likes Posting my Waist circumference technique numbers with the method attached so they can be discounted properly. Uncontrolled, unblinded, and collected by someone who…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #76 · Data & Tools › Calculators · 20 May 2026 · 10 likes Confirming post #73 from a second method, which matters more than confirming it from a second person. A tool that refuses to give an answer when the result falls below…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #57 · Compounds › Repair & healing peptides · 20 May 2026 · 32 likes Answering the question post #55 raises rather than the one it answers. The pentadecapeptide sequence is short and stable enough to survive conditions that would degrade…
-
Official shortage notices and what they authorise Replied, post #33 · Access › Shortages · 4 May 2026 · 5 likes Compounding during shortages: some jurisdictions allow pharmacy compounding when a marketed product is in shortage. That permission is jurisdiction-specific and…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #25 · Safety › Contraindications · 1 May 2026 · 24 likes Somebody's condition being on a list does not settle the decision, and somebody's condition being absent from one does not either. That is the honest state of it as of…
-
Residual solvents and scavengers: what is looked for — what changed since Replied, post #32 · Analytics › Impurities & related substances · 26 Apr 2026 · 11 likes Reading this Residual solvents and scavengers thread as someone who came in with a fixed view: the third and seventh replies moved me and the confident ones did not.
-
Adolescents: a distinct evidence base — one year on Replied, post #88 · Clinical › Special populations · 19 Apr 2026 · 9 likes Answering the question post #86 raises rather than the one it answers. Adding a small correction to the Adolescents summary above rather than a disagreement with it.…
-
Official shortage notices and what they authorise Started this topic · Access › Shortages · 7 Apr 2026 · 31 likes Posting this under the heading it deserves: Official shortage notices and what they authorise Everything below is what sits behind that. Trying to work out what would…
-
Is there a ceiling dose beyond which semaglutide stops adding benefit? Replied, post #2 · Compounds › Semaglutide · 7 Apr 2026 · 11 likes The oral formulation is a genuinely different pharmaceutical problem from the injectable and shares only the active molecule. Absorption enhancers, fasting requirements…
-
Reading a preclinical wound-healing model and its relevance to a human tendon — a second… Replied, post #40 · Compounds › Repair & healing peptides · 12 Mar 2026 · 0 likes For anyone arriving from search engines: this subcategory discusses published preclinical work and the absence of published clinical work. It does not endorse or…
-
Revisiting: Absolute versus relative contraindications Replied, post #38 · Safety › Contraindications · 6 Mar 2026 · 30 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #96 · Pharmacology › Pharmacokinetics · 2 Mar 2026 · 0 likes Practical experience of Half-life, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what make it…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #85 · Meta › Site feedback · 28 Feb 2026 · 2 likes Everything in post #83 holds. The case it does not cover is the one I have. Adding a small correction to the topic list summary above rather than a disagreement with…
-
Measurement error in a self-reported exposure Replied, post #118 · Evidence › Study critique · 27 Feb 2026 · 26 likes That matches what I have seen, for whatever a single anecdote is worth.
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #10 · Compounds › Semaglutide · 25 Feb 2026 · 14 likes Practical note on molecular mass of semaglutide: write down what you expect before you look. The number of times I have found what I went looking for is higher than…
-
Realistic expectations for strength while losing weight quickly Replied, post #65 · Nutrition & Training › Resistance training · 23 Feb 2026 · 21 likes Confirming post #62 from a second method, which matters more than confirming it from a second person. Adaptation and plateau: if strength does not change for weeks,…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #58 · Documentation › Doc review · 8 Feb 2026 · 23 likes On evidence digest, the part that usually goes wrong is that the question is asked as though it has one answer. It has a range, and the width of the range is the…
-
Preprint servers and what screening they do Replied, post #49 · Evidence › Preprints · 8 Feb 2026 · 12 likes Everything in post #45 holds. The case it does not cover is the one I have. Version numbers on a preprint server matter. Citing version one of something now on version…
-
[2026 update] Evidence quality in the secretagogue literature: an honest assessment Replied, post #18 · Compounds › Secretagogues & GH axis · 1 Feb 2026 · 24 likes Before the thread moves on from Evidence quality — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from an n of…
-
Request: export my own posts — one year on Replied, post #41 · Meta › Feature requests · 1 Feb 2026 · 0 likes Request: an export of my own posts. Not for any dramatic reason — I want to search my own history offline, and site search is optimised for finding other people's…
-
Can a home kit substitute for a laboratory report? A careful no Replied, post #121 · Analytics › Home & field testing · 30 Jan 2026 · 0 likes Worth separating two things that post #117 runs together. Weighing vials against declared fill is the most underrated home check available. It needs a balance with…
-
Tracking that stops updating and then resumes — the long version Replied, post #65 · Sourcing › Logistics · 13 Jan 2026 · 9 likes Post #63 put the caveat in the right place and I want to underline it. Peak periods and public holidays affect this more than any other factor and are entirely…
-
Heterogeneity as information rather than as a nuisance Replied, post #59 · Evidence › Meta-analyses · 12 Jan 2026 · 1 like My position on heterogeneity is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #74 · Practice › Side effects · 11 Jan 2026 · 18 likes Vomiting: when it is expected (first-dose reactions or early titration) and when it is a reason to stop and seek help are different. Occasional vomiting during…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #49 · Pharmacology › Receptor biology · 9 Jan 2026 · 0 likes GIP receptor signalling: the glucose-dependent insulinotropic peptide receptor (GIP) is involved in glucose-stimulated insulin secretion. GIP agonism is thought to…
-
The decimal-point error, and the habit that catches it Replied, post #17 · Practice › Reconstitution · 14 Dec 2025 · 1 like Taking post #14 at face value and following it one step further. I would call the community position on decimal-point error likely rather than established, and I would…
-
Dose numbers for oral formulations are not comparable to injectable ones Replied, post #9 · Compounds › Oral incretins · 4 Dec 2025 · 0 likes Taking post #6 at face value and following it one step further. On variability: the between-person spread in exposure for oral semaglutide is wide enough that two…
-
MHRA statements, read directly Replied, post #40 · Regional › UK & Ireland · 30 Nov 2025 · 30 likes Worth separating two things that post #38 runs together. Worth stating the null on MHRA statements before we explain it: the observation may be nothing. That…
-
Temperature loggers worth the money — the long version Replied, post #76 · Devices › Cold chain · 17 Nov 2025 · 4 likes Do not judge cold-chain performance from a single delivery in either direction. It is a distribution and one sample from it is one sample. I would not lead a decision…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #94 · Documentation › Doc review · 16 Nov 2025 · 25 likes Adding the measurement that post #92 says would settle it. Something worth flagging about Promotion criteria: the strongest-sounding claims in this thread are the ones…
-
New subcategory: rationale and scope Replied, post #10 · Meta › Announcements · 12 Oct 2025 · 11 likes The honest answer on new subcategory is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they matter. Most…
-
Batch date after test date, and other internal inconsistencies Replied, post #7 · Analytics › COA interpretation · 8 Oct 2025 · 22 likes Coming back to post #3, because the follow-up matters more than the original answer. Reporting rather than recommending, on batch date. What happened is above. Whether…
-
Reading SURMOUNT-1 without the press release — one year on Replied, post #12 · Compounds › Tirzepatide · 4 Oct 2025 · 0 likes What I would want before treating Reading SURMOUNT-1 without the press as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of…
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #58 · Analytics › HPLC & UHPLC · 3 Oct 2025 · 24 likes Post #55 is the version of this I will quote in future. One addition. Purity by chromatography answers "what proportion of what I detected is the intended species". It…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #124 · Compounds › Tirzepatide · 13 Sep 2025 · 1 like Post #122 describes the usual case. This is about the unusual one. Mass and charge states: tirzepatide is about 4813.5 Da and on an electrospray instrument you would…
-
What the GIP component of tirzepatide is thought to contribute, and how confident we can… Replied, post #33 · Compounds › Tirzepatide · 30 Aug 2025 · 8 likes On the mechanism question specifically: the honest position is that GIP agonism plausibly contributes and that the trial design cannot separate its contribution from…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #70 · Clinical › Special populations · 29 Aug 2025 · 0 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
Thyroid function tests during substantial weight change Replied, post #30 · Clinical › Bloodwork · 14 Aug 2025 · 0 likes Add biological variation and analytical imprecision to that base rate and the probability of a meaningless flag on a multi-analyte panel is substantial.
-
When a preprint is the best available evidence and we say so Replied, post #41 · Evidence › Preprints · 10 Aug 2025 · 23 likes The practical version of preprint is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Discussing something you have already been doing — the long version Replied, post #13 · Clinical › Prescriber conversations · 10 Jul 2025 · 26 likes Prescription logistics: confirm whether it will be filled locally, requires mail order, or will be prescribed off-label and needs a compounding pharmacy. Different…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #55 · Compounds › Semaglutide · 5 Jul 2025 · 0 likes The mass figure differs between sources because of how the different entities report it. The monoisotopic mass of the bare peptide is one number; the mass including the…
-
Reading an MS report that only gives you a single number Replied, post #114 · Analytics › Mass spectrometry · 21 Jun 2025 · 15 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. It is…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #56 · Compounds › Repair & healing peptides · 10 Jun 2025 · 7 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Pre-registering a personal experiment, seriously Replied, post #3 · Research Methods › N-of-1 designs · 25 May 2025 · 4 likes Write down what you would accept as evidence that it did not work, before starting. That one sentence turns an anecdote into an experiment.
-
Reverting an edit that had no revision note Replied, post #2 · Meta › Wiki maintenance · 30 Apr 2025 · 1 like Last maintenance note: the limitations section is the part most likely to be skipped and the part most likely to matter. It belongs above the examples, not at the…
-
Regression to the mean in progress reports Replied, post #4 · Research Methods › Statistics · 25 Apr 2025 · 11 likes The opening post describes the usual case. This is about the unusual one. Regression: I have looked for the primary source twice and failed twice. Either it does not…
-
A well-designed study with a badly written abstract Replied, post #38 · Evidence › Study critique · 22 Apr 2025 · 24 likes A run-in period that excludes non-responders before randomisation changes what the trial is estimating. It is legitimate design and it must be stated in any summary. It…
-
Second pass at: Journal club: STEP 4 and what a withdrawal design can prove Replied, post #10 · Evidence › Journal club · 15 Apr 2025 · 12 likes The documentation on STEP 4 is better than this thread and I say that as someone who has posted in the thread.
-
Reading an MS report that only gives you a single number Replied, post #43 · Analytics › Mass spectrometry · 2 Apr 2025 · 27 likes Picking up post #42: that is the part I would want checked first. Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #57 · Compounds › Cagrilintide & amylin analogues · 29 Mar 2025 · 14 likes Picking up post #54: that is the part I would want checked first. Comparing an amylin analogue to an incretin agonist on weight change alone misses that they were…
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #64 · Documentation › Doc review · 18 Mar 2025 · 13 likes Adding what did not work for me on draft on reconstitution arithmetic, since the failures never get written up and they are half the useful information.
-
When "no data" is the complete and final answer Replied, post #119 · Compounds › Other compounds · 15 Mar 2025 · 0 likes For any compound without a widely available reference standard, retention-time comparisons across laboratories are close to meaningless. Only a mass result travels.
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #113 · Compounds › Other compounds · 12 Mar 2025 · 7 likes Post #111 describes the usual case. This is about the unusual one. I changed my mind about Research-use-only status after someone here asked me for the source and I…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #34 · Sourcing › Regulatory · 28 Feb 2025 · 31 likes The most useful thing anyone has posted about pharmaceutical compounding rules in this category was a table of what had been measured and by whom. That is what I would…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #92 · Sourcing › Regulatory · 24 Feb 2025 · 3 likes Research-use-only material is not approved for human use anywhere. That is a statement about the material's regulatory category rather than about its quality.…
-
Adjudicated events and why the definition matters — the long version Replied, post #17 · Evidence › Trials · 20 Feb 2025 · 8 likes Absolute and relative effects answer different questions. Write down the event rate in each arm and the difference between them; everything quotable is derived from…
-
Distinguishing a deletion sequence by mass alone Replied, post #104 · Analytics › Mass spectrometry · 18 Feb 2025 · 14 likes Positional isomers and epimers are mass-identical. Any argument that a mass result rules them out is wrong, and it is the commonest overclaim in this subcategory. That…
-
Albumin binding and how it produces a long half-life Replied, post #7 · Pharmacology › Pharmacokinetics · 18 Feb 2025 · 18 likes Answering the question post #4 raises rather than the one it answers. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to…
-
Follow-up: What other technical communities get right that we do not Replied, post #18 · Lounge › Off topic · 15 Feb 2025 · 1 like Humour: light, relevant humour is welcome. Cruel humour targeting individuals or groups is not.
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #72 · Data & Tools › Calculators · 31 Jan 2025 · 20 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #24 · Documentation › Doc review · 12 Jan 2025 · 17 likes Worth separating two things that post #20 runs together. Nothing in a maintained document is medical advice and the review should confirm the page says so where it…
-
Recovery when intake is low: what to cut first Replied, post #48 · Nutrition & Training › Resistance training · 12 Jan 2025 · 2 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum.
-
Checking someone else's arithmetic: a worked example thread Replied, post #11 · Practice › Reconstitution · 1 Jan 2025 · 1 like Picking up post #10: that is the part I would want checked first. Preservative effectiveness is tested against a defined microbial challenge under defined conditions.…
-
Washout with a one-week half-life: the arithmetic Replied, post #56 · Research Methods › N-of-1 designs · 3 Dec 2024 · 3 likes Answering the question post #54 raises rather than the one it answers. A note on scope: what I am saying about washout applies to the case in the first post and I would…
-
Identical chromatograms across two different lots Replied, post #55 · Sourcing › Red flags · 28 Nov 2024 · 27 likes Post #54 is right about the mechanism and I think understates the practical bit. Prices well below the rest of the market are a fact rather than a finding. They are…
-
Choosing which test to pay for, given a fixed budget — does this still hold? Replied, post #21 · Sourcing › Independent verification · 6 Nov 2024 · 20 likes Post #17 and I disagree about the size of the effect, not about the direction. The record shows what was measured. Everything beyond that is inference and this site…
-
PIONEER 6 cardiovascular safety, read as a safety trial rather than an efficacy one —… Replied, post #27 · Compounds › Oral incretins · 5 Oct 2024 · 0 likes Taking post #26 at face value and following it one step further. I would call the community position on PIONEER 6 cardiovascular safety likely rather than established,…
-
Revisiting: How to bring a laboratory report to an appointment usefully Replied, post #40 · Clinical › Bloodwork · 19 Sep 2024 · 1 like Noted, and thank you for writing it out rather than summarising it.
-
Correlation in a self-tracked dataset: what it can support Replied, post #99 · Research Methods › Statistics · 24 Aug 2024 · 29 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Coming back to: Purity assay versus content assay: two different numbers Replied, post #39 · Analytics › COA interpretation · 11 Aug 2024 · 4 likes The single most useful discipline: read the document for what it does not say. The omissions are more consistent between suppliers than the numbers are.